Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Medicine

Vol 9 No 2 (2024): December

Adipokines Identify Crucial Biomarkers for Hypertension in Iraq
Adipokin Mengidentifikasi Biomarker Penting untuk Hipertensi di Irak



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.8961
Published
December 15, 2024

Abstract

Adipokines, which are generated by adipose tissue, are biologically active compounds that function similarly to traditional hormones. These proteins are involved in cellular signaling and control or modify several biological processes in target organs such as the brain, liver, muscles, heart, blood vessels, pancreas, and immune system. Adipokines can be incorporated into new diagnostic approaches as biological indicators of different metabolic, inflammatory, and cardiovascular conditions. The study was conducted at Al-Basrah Teaching Hospital on hypertensive patients between December 2022 and March 2023. This study included a sample of fifty-three patients with hypertension, whose ages ranged from 30 to 60 years. The features of these patients were compared to the same variables in a group of fifty-three healthy volunteers aged 30 to 40 years. This study aimed to identify the most significant alterations in serum apelin, spexin, and serum electrolyte levels (sodium, potassium, calcium, magnesium, and chloride) in patients solely diagnosed with hypertension. The analysis involved a statistical examination of the variables. The hypertension group had lower apelin and higher spexin levels than the control group. Additionally, each group had normal electrolyte levels (sodium, potassium, calcium, magnesium, chloride). The control group had somewhat higher potassium, calcium, and chloride levels than the hypertension group. The concentration of apelin does not influence sodium, calcium, magnesium, or chloride. Negative potassium correlation for apelin. However, spexin concentration does not impact sodium, potassium, calcium, or magnesium. Spexin concentrations are negatively correlated with apelin and chloride concentrations.

Highlight:

  1. Adipokines Role: Adipokines are key in cellular signaling affecting multiple organs.
  2. Study Findings: Hypertensive patients showed lower apelin and higher spexin levels.
  3. Serum Electrolyte Levels: normal in both groups, with minor differences in potassium, calcium, and chloride.

Keywoard: Adipokines, Hypertension, Apelin, Spexin, Electrolytes

References

  1. M. Würfel, M. Blüher, M. Stumvoll, T. Ebert, P. Kovacs, A. Tönjes, and J. Breitfeld, "Adipokines as Clinically Relevant Therapeutic Targets in Obesity," Biomedicines, vol. 11, no. 5, p. 1427, May 2023.
  2. Y. Nasir, F. Farzollahpour, A. Mirzababaei, Z. Maghbooli, and K. Mirzaei, "Associations of Dietary Fats Intake and Adipokines Levels in Obese Women," Clinical Nutrition ESPEN, vol. 43, pp. 390-396, Jun. 2021.
  3. M. Pakhare and A. Anjankar, "Critical Correlation Between Obesity and Cardiovascular Diseases and Recent Advancements in Obesity," Cureus, vol. 16, no. 1, Jan. 2024.
  4. Q. A. Qasim, Y. Y. Fareed, M. A. Jabir, and H. B. Sahib, "Evaluation of Chemerin and Apelin Adipokines in Obese and Non-Obese Type 2 Diabetes Mellitus Patients," Int. J. Pharm. Sci. Rev. Res., vol. 40, no. 1, pp. 228-233, Oct. 2016.
  5. H. K. Jaid, F. M. Khaleel, I. N. Salman, and B. A. Abd, "Estimation of Apelin Levels in Iraqi Patients with Type II Diabetic Peripheral Neuropathy," Baghdad Sci. J., vol. 20, no. 5, pp. 1684-1690, Oct. 2023.
  6. M. K. Najim, Q. R. Lahhob, H. J. Abbas, H. A. Alidrisi, Z. J. Ibrahim, Z. K. Budaiwi, Z. H. Abdul-Jabbar, M. J. Kadham, and M. A. Maatook, "Association of Serum Apelin and Atherogenic Indices in Patients with Primary Thyroid Diseases," Eurasian Chem. Commun., vol. 5, no. 7, pp. 588-597, Jul. 2023.
  7. T. Chen, F. Wang, Z. Chu, L. Sun, H. Lv, W. Zhou, J. Shen, L. Chen, and M. Hou, "Circulating Spexin Decreased and Negatively Correlated with Systemic Insulin Sensitivity and Pancreatic β Cell Function in Obese Children," Ann. Nutr. Metab., vol. 74, no. 2, pp. 125-131, Feb. 2019.
  8. V. Bitarafan, A. Esteghamati, K. Azam, S. Yosaee, and K. Djafarian, "Comparing Serum Concentration of Spexin Among Patients with Metabolic Syndrome, Healthy Overweight/Obese, and Normal-Weight Individuals," Med. J. Islam. Repub. Iran, vol. 33, p. 93, 2019.
  9. A. Ma, J. Bai, M. He, and A. O. Wong, "Spexin as a Neuroendocrine Signal with Emerging Functions," Gen. Comp. Endocrinol., vol. 265, pp. 90-96, Sep. 2018.
  10. J. W. McEvoy, N. Daya, F. Rahman, R. C. Hoogeveen, R. S. Blumenthal, A. M. Shah, C. M. Ballantyne, J. Coresh, and E. Selvin, "Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline with Incident Cardiovascular Outcomes," JAMA, vol. 323, no. 4, pp. 329-338, Jan. 2020.
  11. E. Berta, I. Lengyel, S. Halmi, A. Erdei, M. Harangi, D. Páll, E. V. Nagy, and M. Bodor, "Hypertension in Thyroid Disorders," Front. Endocrinol., vol. 10, p. 457798, Jul. 2019.
  12. M. A. Muna, H. J. Al-Badri, and N. A. Mousa, "Hypertension Control Among Adult Iraqis," J. Fac. Med. Baghdad, vol. 64, no. 3, pp. 145-152, Oct. 2022.
  13. H. Pan, M. Hibino, E. Kobeissi, and D. Aune, "Blood Pressure, Hypertension and the Risk of Sudden Cardiac Death: A Systematic Review and Meta-Analysis of Cohort Studies," Eur. J. Epidemiol., vol. 35, no. 5, pp. 443-454, May 2020.
  14. E. J. MacLaughlin and J. J. Saseen, "Hypertension," in Pharmacotherapy: A Pathophysiologic Approach, 11th ed., J. T. DiPiro, G. C. Yee, L. Posey, S. T. Haines, T. D. Nolin, and V. Ellingrod, Eds. New York, NY, USA: McGraw Hill, 2020.
  15. American College of Cardiology, American Heart Association, "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults," Hypertension, vol. 71, no. 6, pp. E13-E115, Jun. 2018.
  16. Z. Mahmood, "Serum Potassium and Calcium Level in Patients with Post-Myocardial Infarction Ventricular Fibrillation," Med. J. Basrah Univ., vol. 39, no. 1, pp. 47-53, Jun. 2021.
  17. A. Ivankova, N. Kuzminova, V. Ivanov, and S. Lozinsky, "Changes of Apelin-13 Concentration in Patients with Essential Hypertension and Extrasystole," Arterial Hypertension, vol. 26, no. 4, pp. 141-145, 2022.
  18. M. B. Haffd, U. H. Ramadhan, and K. A. Zaydan, "Apelin and Lipid Profile in Hypertensive Patients: A Correlation Data," Int. J. Clin. Biol. Biochem., vol. 5, no. 1, pp. 85-89, Dec. 2022.
  19. H. Akbari, M. Hosseini-Bensenjan, S. Salahi, A. Moazzen, H. Aria, A. Manafi, S. Hosseini, M. Niknam, and G. Asadikaram, "Apelin and its Ratio to Lipid Factors are Associated with Cardiovascular Diseases: A Systematic Review and Meta-Analysis," PLoS One, vol. 17, no. 8, p. e0271899, Aug. 2022.
  20. M. Mohammadi, M. Mohamadi, A. Moradi, H. A. Ramawad, P. Gharin, Y. Azizi, and M. Yousefifard, "Apelin as a Candidate for Hypertension Management: A Systematic Review and Meta-Analysis on Animal Studies," Arch. Acad. Emerg. Med., vol. 10, no. 1, 2022.
  21. M. Hemmati, F. Abharzanjani, and T. Kazemi, "Comparing the Apelin Level in Hypertensive Patients Who Received Hypertension Drugs," Mod. Care J., vol. 17, no. 4, Oct. 2020.
  22. M. Zaki, S. Kamal, W. Ezzat, N. Hassan, W. Yousef, H. Ryad, R. Mohamed, E. Youness, W. Basha, and Y. Elhosary, "Serum Apelin Levels and Metabolic Risk Markers in Obese Women," J. Genet. Eng. Biotechnol., vol. 15, no. 2, pp. 423-429, Dec. 2017.
  23. A. Khadir, S. Kavalakatt, D. Madhu, S. Devarajan, J. Abubaker, F. Al-Mulla, and T. A. Tiss, "Spexin as an Indicator of Beneficial Effects of Exercise in Human Obesity and Diabetes," Sci. Rep., vol. 10, no. 1, p. 10635, Jun. 2020.
  24. Y. Liu, L. Sun, L. Zheng, M. Su, H. Liu, Y. Wei, D. Li, C. Wang, Y. Dai, Y. Gong, C. Zhao, and Y. Sun, "Spexin Protects Cardiomyocytes from Hypoxia-Induced Metabolic and Mitochondrial Dysfunction," Naunyn-Schmiedebergs Arch. Pharmacol., vol. 393, pp. 25-33, Jan. 2020.
  25. A. Gadad, S. Mohammed, V. Sundaram, S. B. Nayak, A. R. Mohammed, and T. G. Ramnanansingh, "Identification of Calcium, Sodium, Magnesium and Chloride Ion Levels in Hypertensive and Non-Hypertensive Trinidadians," Int. J. Biochem. Mol. Biol., vol. 10, no. 3, p. 17, 2019.
  26. D. Wu, Y. Chen, H. Guan, and Y. Sun, "Association of Abnormal Serum Electrolyte Levels with Hypertension in a Population with High Salt Intake," Public Health Nutr., vol. 22, no. 9, pp. 1635-1645, Jun. 2019.
  27. A. S. Abdul-Razak, N. S. Alsharba, and N. F. Neamah, "Ferritin Level and Blood Parameters in Patients with Hypertension and Diabetes," J. Pharm. Negat. Results, pp. 572-575, Sep. 2022.
  28. M. I. Pikilidou, A. N. Lasaridis, P. A. Sarafidis, I. M. Tziolas, P. E. Zebekakis, N. V. Dombros, and E. Giannoulis, "Blood Pressure and Serum Potassium Levels in Hypertensive Patients Receiving or Not Receiving Antihypertensive Treatment," Clin. Exp. Hypertens., vol. 29, no. 8, pp. 563-573, Jan. 2007.
  29. M. L. Krogager, C. Torp-Pedersen, R. N. Mortensen, L. Køber, G. Gislason, P. Søgaard, and K. Aasbjerg, "Short-Term Mortality Risk of Serum Potassium Levels in Hypertension: A Retrospective Analysis of Nationwide Registry Data," Eur. Heart J., vol. 38, no. 2, pp. 104-112, Jan. 2017.
  30. X. Y. Wu, T. S. Han, J. G. Gao, Y. L. Zhang, S. N. Zhao, R. B. Sun, C. H. Sun, Y. C. Niu, and Y. Li, "Association of Serum Calcium and Insulin Resistance with Hypertension Risk: A Prospective Population-Based Study."
  31. T. Cundy, A. Grey, and I. R. Reid, "Calcium, Phosphate and Magnesium," in Clinical Biochemistry: Metabolic and Clinical Aspects. New York, NY, USA: Elsevier, 2008.
  32. G. Diwakr Naidu and B. P. Naik, "A Study on Serum Calcium in Patients with Essential Hypertension: A Cross Sectional Study."
  33. D. Fiorentini, C. Cappadone, G. Farruggia, and C. Prata, "Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to its Deficiency," Nutrients, vol. 13, no. 4, p. 1136, Mar. 2021.
  34. C. Thongprayoon, W. Cheungpasitporn, P. Hansrivijit, S. Thirunavukkarasu, A. Chewcharat, J. Medaura, M. A. Mao, and K. Kashani, "Association of Serum Chloride Level Alterations with In-Hospital Mortality," Postgrad. Med. J., vol. 96, no. 1142, pp. 731-736, Dec. 2020.
  35. A. Takahashi, K. Maeda, K. Sasaki, S. Doi, A. Nakashima, T. Doi, and T. Masaki, "Relationships of Hyperchloremia with Hypertension and Proteinuria in Patients with Chronic Kidney Disease," Clin. Exp. Nephrol., vol. 26, no. 9, pp. 880-885, Sep. 2022.
  36. L. McCallum, P. Jeemon, C. E. Hastie, R. K. Patel, C. Williamson, A. M. Redzuan, J. Dawson, J. Sloan, W. Muir, D. Morrison, and G. T. McInnes, "Serum Chloride is an Independent Predictor of Mortality in Hypertensive Patients," Hypertension, vol. 62, no. 5, pp. 836-843, Nov. 2013.
  37. A. M. Al-Samarraie, M. J. Humesh, and Z. A. Al-Samarraie, "Apelin Levels and its Relationship with a Number of Electrolytes in Patients with Myocardial Infarction," Tikrit J. Pure Sci., vol. 23, no. 3, pp. 16-22, May 2018.
  38. M. A. Said, N. Y. Nafeh, and H. A. Abdallah, "Spexin Alleviates Hypertension, Hyperuricaemia, Dyslipidemia and Insulin Resistance in High Fructose Diet Induced Metabolic Syndrome in Rats via Enhancing PPAR-ɣ and AMPK and Inhibiting IL-6 and TNF-α," Arch. Physiol. Biochem., vol. 129, no. 5, pp. 1111-1116, Sep. 2023.

Downloads

Download data is not yet available.